Unlock instant, AI-driven research and patent intelligence for your innovation.
A substituted pyrazolo[1,5-a]pyrimidine compound and its preparation method and application
What is Al technical title?
Al technical title is built by PatSnap Al team. It summarizes the technical point description of the patent document.
A compound, 5-a technology, used in drug combinations, organic chemistry, pharmaceutical formulations, etc.
Active Publication Date: 2022-06-14
LIAONING UNIVERSITY
View PDF7 Cites 0 Cited by
Summary
Abstract
Description
Claims
Application Information
AI Technical Summary
This helps you quickly interpret patents by identifying the three key elements:
Problems solved by technology
Method used
Benefits of technology
Problems solved by technology
[0004] At present, the following problems mainly exist in the research of c-Met inhibitors: the clinical application has relatively high toxicity and side effects, the clinical treatment effect and pharmacokinetic parameters are not ideal, and the oral biological Utilization is not high
The present invention relates to a novel substituted pyrazolo[1,5-a]pyrimidine compound as a c-Met inhibitor, which has not been reported in the literature
Method used
the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more
Image
Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
Click on the blue label to locate the original text in one second.
Reading with bidirectional positioning of images and text.
Smart Image
Examples
Experimental program
Comparison scheme
Effect test
Embodiment 1
[0092]
[0093] Step 1: Synthesis of ethyl 4-phenyl-2,4-dioxobutanoate
[0094]
[0095] Metalsodium particles (11.5 g, 0.50 mol) were added in batches to 400 mL of cooled ethanol, and the reaction was stirred until the sodium particles disappeared, and then warmed to room temperature. Diethyl oxalate (36.5 g, 0.25 mol) and acetophenone (30.0 g, 0.25 mol) were added to the above solution, and the temperature was raised to 70° C., stirred for 5 h, most of the ethanol was removed by evaporation under reduced pressure, and the residue was added to 500 mL of water. . Ethyl acetate was extracted twice, 200 mL each time, and the ethyl acetate phase was discarded. The aqueous phase was adjusted to pH 4 with concentrated hydrochloric acid, extracted three times with ethyl acetate, 150 mL each time, combined the ethyl acetate phases, washed with water three times, 200 mL each time, and the organic phase was dried over anhydroussodiumsulfate and evaporated under reduced pressu...
[0136] Example 4: N-{3-fluoro-4-[6-methoxy-7-(3-morpholine propoxy)quinoline-4-oxyl]phenyl}-7-(4-trifluoro Synthesis of Methylphenyl)pyrazolo[1,5-a]pyrimidine-5-carboxamide (Compound 4)
the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More
PUM
Login to View More
Abstract
The present invention provides a novel substituted pyrazolo[1,5‑a]pyrimidine compound and its preparation method and application. Specifically, the present invention relates to a pyrazolo[1,5 ‑a] quinoline derivatives of pyrimidine and pharmaceutically acceptable salts thereof, wherein the substituents X, Ar, and A have the meanings given in the description. The present invention also relates to compounds of general formula (I) having a strong inhibitory effect on c-Met kinase, and also relates to the use of such compounds and pharmaceutically acceptable salts thereof in the preparation of treatment and / or prevention of c-Met kinase due to abnormally high c-Met kinase Use in medicines expressing the diseases caused, especially in the preparation of medicines for treating and / or preventing cancer.
Description
technical field [0001] The present invention relates to novel 4-phenoxy substituted quinoline compounds containing pyrazolo[1,5-a]pyrimidine and pharmaceutically acceptable salts thereof, their preparation methods and pharmaceutical compositions containing the compounds . The present invention also relates to the use of the compounds and their pharmaceutically acceptable salts in the preparation of medicines for the treatment of diseases caused by abnormally high expression of c-Met kinase, especially in the preparation of medicines for the treatment and / or prevention of cancer . technical background [0002] Cancer, also known as malignant tumor, is a common and frequently-occurring disease that seriously threatens human life and health. Dysregulation of proteintyrosine kinases (PTK) will activate multiple downstream signaling pathways, induce a series of physiological activities of tumor cells such as proliferation, differentiation, invasion, growth, etc., and eventuall...
Claims
the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More
Application Information
Patent Timeline
Application Date:The date an application was filed.
Publication Date:The date a patent or application was officially published.
First Publication Date:The earliest publication date of a patent with the same application number.
Issue Date:Publication date of the patent grant document.
PCT Entry Date:The Entry date of PCT National Phase.
Estimated Expiry Date:The statutory expiry date of a patent right according to the Patent Law, and it is the longest term of protection that the patent right can achieve without the termination of the patent right due to other reasons(Term extension factor has been taken into account ).
Invalid Date:Actual expiry date is based on effective date or publication date of legal transaction data of invalid patent.